Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
11 May 2022 On business and financial situation The Company releases the first quarter 2022 financial results presentation Download
11 May 2022 Announcement of general shareholders’ meeting Rovi releases the information related to its 2022 General Shareholders Meeting Download
11 May 2022 On Corporate Governance The Company informs about the appointment of a new member in its Board of Directors       Download
05 Apr 2022 Liquidity and counterparty agreements The Company communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A.  Download
29 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted on 28 March 2022 and end of the share buyback program Download

Pages

Date Title Description PDF
31 Jan 2020 R&D: new licenses, patents and registered trademarks The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union Download
08 Jan 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2019 Download
20 Dec 2019 Composition of the board of directors The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees. Download
24 Nov 2019 Strategic plans, profit forecasts and presentations The Company releases the presentation related to its strategy update because of the 2019 Investor Day. Download
07 Nov 2019 Information on P&L ROVI releases the press release related to the first nine months 2019 financial results Download

Pages